Phosphatidylinositol 3-kinase p110δ expression in Merkel cell carcinoma

The prognosis of stage III/IV Merkel cell carcinoma (MCC) is very poor. The Phosphatidylinositol 3-kinase p110δ specific inhibitor idelalisib has recently been reported to induce complete clinical remission in a stage IV MCC patient. Here we assessed the expression of p110δ in primary MCC and MCC ce...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Oncotarget
Autors principals: Chteinberg, Emil, Rennspiess, Dorit, Sambo, Ryan, Tauchmann, Samantha, Kelleners-Smeets, Nicole W.J., Winnepenninckx, Véronique, Speel, Ernst-Jan, Kurz, Anna Kordelia, Zenke, Martin, zur Hausen, Axel
Format: Artigo
Idioma:Inglês
Publicat: Impact Journals LLC 2018
Matèries:
Research Paper
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6049866/
https://ncbi.nlm.nih.gov/pubmed/30038704
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.25619
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars